---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-23-001206"
form_type: "8-K"
ticker: "AXIM"
cik: "0001514946"
company_name: "AXIM BIOTECHNOLOGIES, INC."
filed_at: "2023-05-30T23:59:59+00:00"
generated_at: "2026-06-14T11:37:43.015771+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AXIM Biotechnologies issues $575K in convertible notes with 3.75% interest and variable conversion price

## Summary
- Aggregate principal of $575,000: $325,000 cash from four notes, $250,000 to repay prior advances.
- Interest rate 3.75% per annum, payable annually starting May 23, 2024; maturity May 23, 2033.
- Conversion price is lesser of $0.01 or 70% of average of two lowest closing prices in prior 10 trading days.
- Notes are unsecured; no prepayment without holder consent; includes 4.9% beneficial ownership blocker.
- Event of default allows holder to accelerate all principal and accrued interest.

## SEC filing metadata
- accession: 0001096906-23-001206
- form_type: 8-K
- ticker: AXIM
- cik: 0001514946
- company_name: AXIM BIOTECHNOLOGIES, INC.
- filed_at: 2023-05-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514946/000109690623001206/0001096906-23-001206-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514946/000109690623001206/axim-20230523.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-23-001206
- JSON: https://secwatch.observer/filing/0001096906-23-001206.json
- Plain text: https://secwatch.observer/filing/0001096906-23-001206.txt

## Key facts
- Debt Financings
  AXIM BIOTECHNOLOGIES, INC. incurred convertible notes of $575,000 with certain investors at 3.75% per annum maturing May 23, 2033.
  - Instrument: convertible notes
  - Principal: $575,000
  - Counterparty: certain investors
  - Rate: 3.75% per annum
  - Maturity: May 23, 2033
  - Event: incurrence
  source text: On May 23, 2023, AXIM Biotechnologies, Inc. (the “Company”) issued five (5) convertible promissory notes in the aggregate principal amount of $575,000 (the "Convertible Notes") to certain investors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514946/000109690623001206/0001096906-23-001206-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.